Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Fielmann AG

FLMNFPNK
Healthcare
Medical - Instruments & Supplies
$52.85
$0.00(0.00%)
U.S. Market opens in 1h 34m

Fielmann AG Fundamental Analysis

Fielmann AG (FLMNF) shows moderate financial fundamentals with a PE ratio of 21.24, profit margin of 7.55%, and ROE of 19.74%. The company generates $2.4B in annual revenue with strong year-over-year growth of 14.98%.

Key Strengths

No significant strengths identified.

Areas of Concern

PEG Ratio3.29
We analyze FLMNF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 60.4/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
60.4/100

We analyze FLMNF's fundamental strength across five key dimensions:

Efficiency Score

Weak

FLMNF struggles to generate sufficient returns from assets.

ROA > 10%
7.63%

Valuation Score

Moderate

FLMNF shows balanced valuation metrics.

PE < 25
21.24
PEG Ratio < 2
3.29

Growth Score

Excellent

FLMNF delivers strong and consistent growth momentum.

Revenue Growth > 5%
14.98%
EPS Growth > 10%
21.48%

Financial Health Score

Excellent

FLMNF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.57
Current Ratio > 1
1.15

Profitability Score

Weak

FLMNF struggles to sustain strong margins.

ROE > 15%
19.74%
Net Margin ≥ 15%
7.55%
Positive Free Cash Flow
No

Key Financial Metrics

Is FLMNF Expensive or Cheap?

P/E Ratio

FLMNF trades at 21.24 times earnings. This indicates a fair valuation.

21.24

PEG Ratio

When adjusting for growth, FLMNF's PEG of 3.29 indicates potential overvaluation.

3.29

Price to Book

The market values Fielmann AG at 4.04 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.04

EV/EBITDA

Enterprise value stands at 7.37 times EBITDA. This is generally considered low.

7.37

How Well Does FLMNF Make Money?

Net Profit Margin

For every $100 in sales, Fielmann AG keeps $7.55 as profit after all expenses.

7.55%

Operating Margin

Core operations generate 16.31 in profit for every $100 in revenue, before interest and taxes.

16.31%

ROE

Management delivers $19.74 in profit for every $100 of shareholder equity.

19.74%

ROA

Fielmann AG generates $7.63 in profit for every $100 in assets, demonstrating efficient asset deployment.

7.63%

Following the Money - Real Cash Generation

Operating Cash Flow

Fielmann AG generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Fielmann AG generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

FLMNF converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

21.24

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

3.29

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.04

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.61

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.57

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.20

vs 25 benchmark

ROA

Return on assets percentage

0.08

vs 25 benchmark

ROCE

Return on capital employed

0.22

vs 25 benchmark

How FLMNF Stacks Against Its Sector Peers

MetricFLMNF ValueSector AveragePerformance
P/E Ratio21.2428.25 Better (Cheaper)
ROE19.74%780.00% Weak
Net Margin7.55%-20122.00% (disorted) Weak
Debt/Equity0.570.30 Weak (High Leverage)
Current Ratio1.154.66 Neutral
ROA7.63%-14687.00% (disorted) Weak

FLMNF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Fielmann AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

48.88%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-11.67%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

35.90%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ